Venture Capital

Unicircles Rank: 57
Early stage venture firm focused on life science discoveries to prevent, detect and cure disease.
Over 30 years, ARCH has backed disruptive science companies with as little as $50K to as much as hundreds of millions of dollars, per company. We are not interested in following the crowd. We are contrarian, bold, and imaginative risk takers. We follow the science to found companies based on revolutionary technologies that can impact people’s lives. We take a long-term view when building companies. That’s why we are flexible in our approach and size our portfolio company investments as needed. Our extended network of partners helps us build companies through the formation stages and grow to their full potential.
Community Valuation
Undervalued (1 vote undervalued, 0 votes overvalued)
Unicircles Rating:
61%
(Ranked #56, 1 vote)
Investment preferences:
Mid-stage Expansion Capital (VC, PE)
Investment Sector:
Analytics / Algorithms / AI, Biotech / Health Care, Clean / Green Tech, Consumer E-Commerce, and FinTech / Investments
Common Investment amount:
25M+ (USD)
Assets under Mgmt:
1B - 5B (USD)
Nearest Metro Area:
PRIMARY CONTACTS
Board / CXO / Strategy / Partner
Ambassadors
TEAM
Ratings & Reviews
Entrepreneurship
Portfolio Companies
OPPORTUNITIES AT ARCH Venture Partners